With the rise in adoption of agentic AI by companies for automation and increasing complexities of the newer versions, cybersecurity concerns have grown exponentially. Enterprises and businesses need ...

A new physics study challenges the simulation hypothesis, arguing that the universe contains realities that can likely never ...

Recursion Pharmaceuticals ( RXRX 1.39%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

Discover Denario, the new open-source AI that automates the entire scientific process, from generating hypotheses to ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Recursion Pharmaceuticals, Inc (($RXRX)) has held its Q3 earnings call. Read on for the main highlights of the call. Recursion Pharmaceuticals, ...

Cowichan Tribes members have voted overwhelmingly in favour of a new education law that would allow them to create an education system for their children. Eighty-nine per cent of the 307 votes cast ...

Welcome to Play Smart, a regular GOLF.com game-improvement column that will help you become a smarter, better golfer. To generate your maximum power, you’ve got to know how to properly shift your ...

Atlantic Health and St. Peter's Healthcare System have ended plans to merge into a single entity, with the decision coming after an analysis of the “rapidly evolving” national healthcare landscape.

Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 26,086 calls trading, 1.1x expected, and implied vol increasing almost 32 points to 119.88%. 10/31 weekly 6 calls and Oct-25 5.5 ...